Precision BioSciences Inc(纳斯达克代码:DTIL)近日公布了其2025财年第四季度及全年的财务业绩报告,同时向市场同步了公司最新的业务发展动态。此次披露涵盖了公司在指定时期内的关键财务数据与运营里程碑,为投资者提供了全面的业绩概览。
Precision BioSciences Inc(纳斯达克代码:DTIL)近日公布了其2025财年第四季度及全年的财务业绩报告,同时向市场同步了公司最新的业务发展动态。此次披露涵盖了公司在指定时期内的关键财务数据与运营里程碑,为投资者提供了全面的业绩概览。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.